NASDAQ NMS - GLOBAL MARKET · FBIO
-0.49% · -$0.0100 · Vol 146.2K
Market closed · last close 4:00 PM ET · price as of 16:58:40 ET
Fortress Biotech Inc

Fortress Biotech Inc

Biotechnology
$2.04
Card
Relationship Map

Follow $FBIO

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $FBIO by email

Veridion Score

BETAMEDIUM CONF · 6 of 6 factors measuredMethodology
FBIO
Fortress Biotech Inc
Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Middle range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

55/ 100
Veridion Score
Middle range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Wed Oct 7 · last completed session · Markets closed · resumes Thu 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is FBIO moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading FBIO catalysts
About Fortress Biotech Inc
PHARMACEUTICAL PREPARATIONS
Listed since
2011
Employees
78
Country
US

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$2.02
Day high
$2.06
Day low
$2.00
Previous close
$2.05
52W high
$4.38
-53.42% from high
52W low
$2.00
2% of range
Market cap
$68.4M
P/E
0.61×
EPS
$2.91
Beta
0.89
Shares out
33.4M
Volume
146.2K
0.50× rel vol
Avg volume
290.5K
VWAP
$2.04
Price history computed in-house
1W
-1.45%
1M
-24.72%
3M
-38.18%
1Y
-29.90%
YTD
-44.26%
SMA 50 $2.62 · below
SMA 200 $2.95 · below
52W position 2%

FBIO overview

Veridion Score
55
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around FBIO.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading FBIO Form 4 filings
Public disclosures

Congress activity in FBIO

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified filings found.

Federal contracts

FBIO contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for FBIO in this window.
Lobbying spend

FBIO lobbying filings, year to date.

Registered lobbying filings matched to Fortress Biotech Inc.

$40.0K
Refresh interval: 12hSource: LDA disclosure filings
Health Issues
Filing
$20.0K
FORTRESS BIOTECH INC.

THE VOGEL GROUP

Apr 20, 2026
Filing
$20.0K
FORTRESS BIOTECH INC.

THE VOGEL GROUP

Jan 20, 2026
Loading news for FBIO
Analyst ratings
Sovereign unlock shows live analyst consensus for FBIO.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.